Successful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae

Zhang, Siping; Zhu, Kunju; Zhang, Chi

doi:10.1016/j.abd.2020.03.004

Cited by 7 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To the best of our knowledge, there has been only one reported case of co-infection with mucormycosis and K. pneumoniae so far, but in contrast to our patient, that was a case of isolated cutaneous mucormycosis [12].…”

Section: Discussioncontrasting

confidence: 82%

Rhino-Orbital Mucormycosis in a COVID-19 Patient Co-Infected With Klebsiella Pneumoniae

Wadhwa¹,

Khurana²

2021

Cureus

View full text Add to dashboard Cite

We present a case of a 34-year-old male with coronavirus disease 2019 and uncontrolled blood sugar with right orbital cellulitis and right ethmoidal and maxillary sinusitis. Histopathology of a middle meatus tissue biopsy collected via diagnostic nasal endoscopy (DNE) revealed the presence of Mucor and Klebsiella pneumoniae (K. pneumoniae). After the administration of intravenous (IV) insulin, cefoperazonesulbactam, and posaconazole (due to the non-availability of amphotericin B), he underwent surgical debridement and functional endoscopic sinus surgery (FESS). After being on antibiotics and antifungals for two weeks post-surgery, the patient had a favorable outcome and further tests revealed improved blood counts and inflammatory markers.

show abstract

Section: Discussioncontrasting

confidence: 82%

Rhino-Orbital Mucormycosis in a COVID-19 Patient Co-Infected With Klebsiella Pneumoniae

Wadhwa¹,

Khurana²

2021

Cureus

View full text Add to dashboard Cite

show abstract

“…In this observation, we uncover a new phenomenon in which Mucorales fungi suppress a critical innate effector function in activated macrophages and propose that Mucorales fungi exert this phenomenon by at least two different mechanisms: one that involves the active removal of NO from the media and another that requires direct contact with macrophages. Our findings have implications for co-infections or co-occurrence of Mucorales with other pathogens, such as Gram-negative bacteria ( 18 – 20 ), SARS-CoV-2, and other fungi ( 21 ). Specifically, by depleting NO, Mucorales may prevent macrophages from appropriately responding to these co-infecting pathogens.…”

Section: Discussionmentioning

confidence: 88%

Mucorales fungi suppress nitric oxide production by macrophages

Soare,

Bruno

2024

mBio

View full text Add to dashboard Cite

Mucormycosis is classified by the National Institute of Allergy and Infectious Diseases as an emerging disease and is caused by Mucorales fungi. Despite the high morbidity and mortality rates associated with the disease, little is known about the host-pathogen interactions that dictate disease progression. The recent surge of mucormycosis cases among COVID-19 patients has thrust the disease and the lack of available treatments into the spotlight. Despite severe fungal angioinvasion and tissue necrosis during infection, clinical observations suggest a lack of pro-inflammatory responses. Understanding immune evasion mechanisms in mucormycosis can help guide potential therapeutic options. In this study, we demonstrate that Mucorales fungi can suppress the accumulation of nitric oxide (NO) in lipopolysaccharide- and interferon gamma-stimulated macrophages despite robust expression of the Nos2 mRNA and inducible nitric oxide synthase protein. This suppressive activity requires fungal viability and direct contact with macrophages and is not due to restricted access to L-arginine substrate. While Mucorales fungi appear to be able to remove NO from its environment, it does not account for the full suppression that we observe and suggests that Mucorales employs at least two mechanisms. Future experiments will elucidate the mechanisms by which Mucorales fungi deplete NO accumulation by macrophages and the implications of this depletion in mucormycosis pathogenesis. IMPORTANCE In October 2022, Mucorales fungi were listed in the “High Priority Group” on the first-ever list of fungal priority pathogens by the World Health Organization. As the causative agent of mucormycosis, Mucorales have become of great clinical and public health importance with growing mucormycosis numbers, notably with the exponential rise of COVID-19-associated mucormycosis cases. Despite the dire need, there are limited therapeutic options to treat mucormycosis. Our research fills in critical gaps of knowledge about how Mucorales fungi evade the host immune system. Specifically, we offer evidence that Mucorales block nitric oxide production, which is a key mediator and signaling molecule of the mammalian innate immune response to microbial pathogens. Our work offers new insight into immune evasion mechanisms by Mucorales fungi.

show abstract

Amphotericin B

2020

Reactions Weekly

View full text Add to dashboard Cite

Successful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae

Cited by 7 publications

References 5 publications

Rhino-Orbital Mucormycosis in a COVID-19 Patient Co-Infected With Klebsiella Pneumoniae

Rhino-Orbital Mucormycosis in a COVID-19 Patient Co-Infected With Klebsiella Pneumoniae

Mucorales fungi suppress nitric oxide production by macrophages

Amphotericin B

Contact Info

Product

Resources

About